Clinical features and brain MRI volumetric changes in anti‐mGluR5 encephalitis
Annals of Clinical and Translational Neurology · 2023-08 · 10 (8) · 1407-1416
DOI: 10.1002/acn3.51831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 16.06.2023. Verfasst von Yueqian Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Encephalitis, Sleep Wake Disorders. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Beijing Municipality, Capital Health Research and Development of Special Fund.
Abstract (Originalsprache)
Background
Anti‐metabotropic glutamate receptor 5 (mGluR5) encephalitis is a rare and under‐recognized autoimmune encephalitis. This study is conducted to characterize its clinical and neuroimaging features.
Methods
Twenty‐nine patients with anti‐mGluR5 encephalitis (15 new cases identified in this study and 14 previously reported cases) were included in this study and their clinical features were characterized. Brain MRI volumetric analysis using FreeSurfer software was performed in 9 new patients and compared with 25 healthy controls at both early (≤6 months of onset) and chronic (>1 year of onset) disease stages.
Results
The common clinical manifestations of anti‐mGluR5 encephalitis included cognitive deficits ( n = 21, 72.4%), behavioral and mood disturbances ( n = 20, 69%), seizures ( n = 16, 55.2%), and sleep disorder ( n = 13, 44.8%). Tumors were observed in 7 patients. Brain MRI T2/FLAIR signal hyperintensities were observed predominantly in mesiotemporal and subcortical regions in 75.9% patients. MRI volumetric analysis demonstrated significant amygdala enlargement in both early and chronic disease stages compared to healthy controls ( P < 0.001). Twenty‐six patients had complete or partial recovery, one remained stable, one died and one was lost to follow‐up.
Conclusion
Our findings demonstrated that cognitive impairment, behavioral disturbance, seizures, and sleep disorder are the prominent clinical manifestations of anti‐mGluR5 encephalitis. Most patients showed a good prognosis with full recovery, even in the paraneoplastic disease variants. The amygdala enlargement in the early and chronic disease stages is a distinct MRI feature, which exploratively offer a valuable perspective for the study of the disease processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- National Center for Clinical Medicine of Neurological Diseases, Beijing, China.
- Department of Neurology, The University of Chicago, Chicago, USA.
- Department of Neurology, Henan Provincial People's Hospital, Zhengzhou, China.
- Department of Neurology, Chinese PLA General Hospital, Beijing, China.
- Department of Neurology, The Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
ORCID-Profile: Yueqian Sun, Guoping Ren, Qun Wang
Förderung
- Natural Science Foundation of Beijing Municipality
- Capital Health Research and Development of Special Fund
Zitieren
APA
Sun, Y., Tao, J. X., Han, X., Wang, X., Zhu, Y., Lian, Y., Ren, G., & Wang, Q. (2023). Clinical features and brain MRI volumetric changes in anti‐mGluR5 encephalitis. Annals of Clinical and Translational Neurology, 10(8), 1407-1416. https://doi.org/10.1002/acn3.51831
Vancouver
Sun Y, Tao JX, Han X, Wang X, Zhu Y, Lian Y, et al. Clinical features and brain MRI volumetric changes in anti‐mGluR5 encephalitis. Annals of Clinical and Translational Neurology. 2023;10(8):1407-1416. doi:10.1002/acn3.51831
BibTeX
@article{Sun2023,
author = {Sun, Yueqian and Tao, James X and Han, Xiong and Wang, Xiangqing and Zhu, Yulan and Lian, Yajun and Ren, Guoping and Wang, Qun},
title = {Clinical features and brain MRI volumetric changes in anti‐mGluR5 encephalitis},
journal = {Annals of Clinical and Translational Neurology},
year = {2023},
volume = {10},
number = {8},
pages = {1407--1416},
doi = {10.1002/acn3.51831}
}
EUVIMED